Division of Molecular Pharmacology and Neuroscience
Nagasaki University Graduate School of Biomedical Sciences
publication
Home
Message
Members
Research
Publication
Access
 
Nagasaki University Center for Pain Research
Related Links
Contact Us
 
 
Publication
Home > Publication >Reviews, Abstracts

Reviews, Abstracts
  1. Ueda H Lysophosphatidic acid signaling is the definitive mechanism underlying neuropathic pain.PAIN. 158(4):55-65,2017.4
  2. Ueda H,Uchida H. Epigenetic Modification in Neuropathic Pain.Curr Pharm Des. 21(7)849-67.2015            
  3. Pavone F, Ueda H:Bridging the Gap Is BoNT/B useful for pain treatment?. PAIN 155(4)674-684,2014
  4. Ueda H, Matsunaga H, Olaposi Omotuyi I., Nagai J: Lysophosphatidic acid: Chemical signature of neuropathic pain. Biochim Biophys Acta. 1831(1): 61-73, 2012
  5. Ueda H, Matsunaga H, Halder S K: Prothymosin alpha plays multifunctional cell robustness roles in genomic, epigenetic, and nongenomic mechanisms. Ann N Y Acad Sci. 1269(1)34-43
  6. Hiroshi Ueda: Lysophosphatidic acid as the initiator of neuropathic pain. Biol Pharm Bull. 34(8):1154-1158, 2011
  7. Hiroshi Ueda and Mutsumi Ueda: Lysophosphatidic acid as initiator of neuropathic pain - biosynthesis and demyelination. Clin Lipidol. 6(2):147-158, 2011
  8. Ueda H, Matsunaga H, Uchida H, Ueda M: Prothymosin Alpha as Robustness Molecule against Ischemic Stress to Brain and Retina. Ann N Y Acad Sci 1194: 20-26, 2010
  9. Ueda H: Prothymosin alpha and cell death mode switch, a novel target for the prevention of cerebral ischemia-induced damage. Pharmacology & Therapeutics, 2009 Sep;123(3):323-33. Epub 2009 Jun 3.
  10. Ueda H, Ueda M: Mechanisms underlying morphine analgesic tolerance and dependence ? plasticity in opioid receptor signaling, trafficking and neural networks. Frontiers in Bioscience, 2009 Jun 1;14:5260-72.
  11. Ueda H: Peripheral mechanisms of neuropathic pain - involvement of lysophosphatidic acid receptor-mediated demyelination. Mol. Pain Apr 1;4:11, 2008
  12. Ueda H:Prothymosin alpha plays a key role in cell death mode-switch, a new concept for neuroprotective mechanisms in stroke Naunyn-Schmiedeberg’s Archives of Pharmacology. 377(4-6):315-23, 2008
  13. Ueda H; Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms.;Pharmacol Ther. Jan;109(1-2):57-77, 2006
  14. Ueda H.: Locus-Specific Involvement of Anti-Opioid Systems in Morphine Tolerance and Dependence. Annals of the New York Academy of Sciences  Oct;1025:376-82. 2004
  15. Ueda H.: Cell death mode switch from necrosis to apoptosis in brain; Current Topics Mitochondria and Neuroprotection; Bio Pharm. Bull. 27(7); 950-955.
  16. Ueda H.: Foreword; Current Topics Mitochondria and Neuroprotection; Bio Pharm. Bull. 27(7); 949.
  17. Ueda H. and Rashid MH: Morecular mechanisms of neuropathic pain; in Drug News Perspect; 2003 Nov; 16(9); 605-613.
  18. Usdin T.B. Dobolyi A. Ueda H. and Palkovits M.; Emerging functions for tuberoinfundibular peptide of 39 residues; In: Trends Endocrin Met; 2003 Jan;14(1), 14-19.
  19. Yamamoto Y. Ono H. Ueda H. Shimamura M. Nishimura K. and Hazato T.; Spinorphin as an Endogenous Inhibitor of Enkephalin-degrading Enzymes: Roles in Pain and Inflammation; Curr Protein Pept Sci.; 2002 Dec; 3(6);587-599.
  20. Yoshida A. and Ueda H.; Neurobiology of lysophosphatidic acid receptor; In: Jpn J Pharmacol.; 2001; 87, 104-109.
  21. Ueda H. In Vivo Molecular Signal Transduction of Peripheral Mechanisms of Pain; In: Jpn. J. Pharmacol.; 1999; 79(3), 263-268.
  22. Misu Y. Goshima Y. Ueda H. and Okamura H.; Neurobiology of L-DOPA ergic system; In: Prog. Neurobiol.; 1996; 49(5): 415-454.
  23. Ueda H. Nozaki M. and Satoh M.; Multiple opioid receptors and GTP-binding proteins; In: Comp. Biochem. and Physiol.; 1991; C 98(1): 157-169.
 
NAGASAKI UNIVERSITY
 
Copyright